אוקטאפלקס IU 500

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

COAGULATION FACTOR II (HUMAN); COAGULATION FACTOR IX (HUMAN- RFIXFC); COAGULATION FACTOR VII (HUMAN); COAGULATION FACTOR X (HUMAN); PROTEIN; PROTEIN C; PROTEIN S ANTIGEN

Commercializzato da:

DOVER MEDICAL & SCIENTIFIC EQUIPMENT LTD, ISRAEL

Codice ATC:

B02BD01

Forma farmaceutica:

אבקה וממס להכנת תמיסה לאינפוזיה

Composizione:

COAGULATION FACTOR IX (HUMAN- RFIXFC) 25 IU/ML; COAGULATION FACTOR II (HUMAN) 14 - 38 IU/ML; COAGULATION FACTOR VII (HUMAN) 9 - 24 IU/ML; COAGULATION FACTOR X (HUMAN) 18 - 30 IU/ML; PROTEIN 13 - 41 MG/ML; PROTEIN C 13 - 31 IU/ML; PROTEIN S ANTIGEN 12 - 32 IU/ML

Via di somministrazione:

תוך-ורידי

Tipo di ricetta:

מרשם נדרש

Prodotto da:

OCTAPHARMA AG, SWITZERLAND

Area terapeutica:

COAGULATION FACTOR IX, II, VII AND X IN COMBINATION

Data dell'autorizzazione:

2021-02-28